These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 19539585)
1. A novel vaccine adjuvant comprised of a synthetic innate defence regulator peptide and CpG oligonucleotide links innate and adaptive immunity. Kindrachuk J; Jenssen H; Elliott M; Townsend R; Nijnik A; Lee SF; Gerdts V; Babiuk LA; Halperin SA; Hancock RE Vaccine; 2009 Jul; 27(34):4662-71. PubMed ID: 19539585 [TBL] [Abstract][Full Text] [Related]
2. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations. Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343 [TBL] [Abstract][Full Text] [Related]
3. Immunization with PCEP microparticles containing pertussis toxoid, CpG ODN and a synthetic innate defense regulator peptide induces protective immunity against pertussis. Garlapati S; Eng NF; Kiros TG; Kindrachuk J; Mutwiri GK; Hancock RE; Halperin SA; Potter AA; Babiuk LA; Gerdts V Vaccine; 2011 Sep; 29(38):6540-8. PubMed ID: 21771625 [TBL] [Abstract][Full Text] [Related]
4. Synthetic innate defence regulator peptide enhances in vivo immunostimulatory effects of CpG-ODN in newborn piglets. Cao D; Li H; Jiang Z; Xu C; Cheng Q; Yang Z; Cao G; Zhang L Vaccine; 2010 Aug; 28(37):6006-13. PubMed ID: 20637306 [TBL] [Abstract][Full Text] [Related]
5. CpG oligodeoxynucleotide synergizes innate defense regulator peptide for enhancing the systemic and mucosal immune responses to pseudorabies attenuated virus vaccine in piglets in vivo. Cao D; Li H; Jiang Z; Cheng Q; Yang Z; Xu C; Cao G; Zhang L Int Immunopharmacol; 2011 Jun; 11(6):748-54. PubMed ID: 21310256 [TBL] [Abstract][Full Text] [Related]
6. Retro-inversion enhances the adjuvant and CpG co-adjuvant activity of host defence peptide Bac2A. Scruten E; Kovacs-Nolan J; Griebel PJ; Latimer L; Kindrachuk J; Potter A; Babiuk LA; Littel-van den Hurk Sv; Napper S Vaccine; 2010 Apr; 28(17):2945-56. PubMed ID: 20193790 [TBL] [Abstract][Full Text] [Related]
7. The mucosal adjuvanticity of the oligodeoxynucleotides containing a non-methylated CpG motif on BCG and diphtheria toxoid. Maeyama J; Komiya T; Takahashi M; Isaka M; Goto N; Yamamoto S Vaccine; 2009 Feb; 27(8):1166-73. PubMed ID: 19136040 [TBL] [Abstract][Full Text] [Related]
8. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen. Mutwiri G; Benjamin P; Soita H; Babiuk LA Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493 [TBL] [Abstract][Full Text] [Related]
9. Novel vaccine formulations against pertussis offer earlier onset of immunity and provide protection in the presence of maternal antibodies. Polewicz M; Gracia A; Garlapati S; van Kessel J; Strom S; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V Vaccine; 2013 Jun; 31(31):3148-55. PubMed ID: 23684829 [TBL] [Abstract][Full Text] [Related]
10. The adjuvant effect of CpG oligodeoxynucleotide linked to the non-toxic B subunit of cholera toxin for induction of immunity against H. pylori in mice. Nyström-Asklin J; Adamsson J; Harandi AM Scand J Immunol; 2008 May; 67(5):431-40. PubMed ID: 18298617 [TBL] [Abstract][Full Text] [Related]
11. Innate defense regulator peptide synergizes with CpG ODN for enhanced innate intestinal immune responses in neonate piglets. Yang J; Mao M; Zhang S; Li H; Jiang Z; Cao G; Cao D; Wang X; Zhang L Int Immunopharmacol; 2012 Feb; 12(2):415-24. PubMed ID: 22226751 [TBL] [Abstract][Full Text] [Related]
12. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections. Hickey DK; Aldwell FE; Beagley KW Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810 [TBL] [Abstract][Full Text] [Related]
13. Co-encapsulation of an antigen and CpG oligonucleotides into PLGA microparticles by TROMS technology. San Román B; Irache JM; Gómez S; Tsapis N; Gamazo C; Espuelas MS Eur J Pharm Biopharm; 2008 Sep; 70(1):98-108. PubMed ID: 18501572 [TBL] [Abstract][Full Text] [Related]
14. The novel complex combination of alum, CpG ODN and HH2 as adjuvant in cancer vaccine effectively suppresses tumor growth in vivo. Tian Y; Li M; Yu C; Zhang R; Zhang X; Huang R; Lu L; Yuan F; Fan Y; Zhou B; Men K; Xu H; Yang L Oncotarget; 2017 Jul; 8(28):45951-45964. PubMed ID: 28515346 [TBL] [Abstract][Full Text] [Related]
15. Identification of a novel vaccine adjuvant that stimulates and maintains diphtheria toxoid immunity. Licciardi PV; Underwood JR Vaccine; 2010 May; 28(22):3865-73. PubMed ID: 20197137 [TBL] [Abstract][Full Text] [Related]
17. Increased potency of BioThrax anthrax vaccine with the addition of the C-class CpG oligonucleotide adjuvant CPG 10109. Gu M; Hine PM; James Jackson W; Giri L; Nabors GS Vaccine; 2007 Jan; 25(3):526-34. PubMed ID: 16973247 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant properties of CpG oligonucleotides in primates. Verthelyi D Methods Mol Med; 2006; 127():139-58. PubMed ID: 16988453 [TBL] [Abstract][Full Text] [Related]
19. Neonatal sublingual vaccination with Salmonella proteins and adjuvant cholera toxin or CpG oligodeoxynucleotides induces mucosal and systemic immunity in mice. Huang CF; Wang CC; Wu TC; Wu KG; Lee CC; Peng HJ J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):262-71. PubMed ID: 18376242 [TBL] [Abstract][Full Text] [Related]
20. The novel adjuvant combination of CpG ODN, indolicidin and polyphosphazene induces potent antibody- and cell-mediated immune responses in mice. Kovacs-Nolan J; Latimer L; Landi A; Jenssen H; Hancock RE; Babiuk LA; van Drunen Littel-van den Hurk S Vaccine; 2009 Mar; 27(14):2055-64. PubMed ID: 19428830 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]